Ghent University Academic Bibliography

Journal Article
A1
open access

Glioma : bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy

Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko (UGent) , Maria V. Vedunova and Dmitri Krysko (UGent)

(2024) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Journal Article
A1
open access

Glioblastoma-associated mesenchymal stem/stromal cells and cancer-associated fibroblasts : partners in crime?

Thibault Lootens (UGent) , Bart Roman (UGent) , Christian Stevens (UGent) , Olivier De Wever (UGent) and Robrecht Raedt (UGent)

(2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 25(4).

Add to list

Miscellaneous

Targeting immunogenic cell death for glioma immunotherapy

Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko (UGent) , Maria V. Vedunova and Dmitri Krysko (UGent)

(2024) TRENDS IN CANCER. 10(1). p.8-11

Add to list

Journal Article
A2
open access

Synthetic whole-slide image tile generation with gene expression profile-infused deep generative models

Francisco Carrillo-Perez, Marija Pizurica (UGent) , Michael G. Ozawa, Hannes Vogel, Robert B. West, Christina S. Kong, Luis Javier Herrera, Jeanne Shen and Olivier Gevaert

(2023) CELL REPORTS METHODS. 3(8).

Add to list

Journal Article
A1
open access

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Sandra Van Lint (UGent) , Alexander Van Parys (UGent) , Bram Van Den Eeckhout (UGent) , Niels Vandamme (UGent) , Stephane Plaisance, Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Elke Rogge (UGent) , Jennifer De Geest (UGent) , Nele Vanderroost (UGent) , et al.

(2023) MOLECULAR CANCER. 22(1).

Add to list

Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma

Bart Vanderborght (UGent) , Kevin De Muynck (UGent) , Eva Gijbels (UGent) , Sander Lefere (UGent) , Charlotte Scott (UGent) , Martin Guilliams (UGent) , Alain Beschin, Mathieu Vinken, Xavier Verhelst (UGent) , Anja Geerts (UGent) , et al.

(2023) INTERNATIONAL JOURNAL OF CANCER. 152(12). p.2615-2628

Add to list

Journal Article
A1
open access

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2023) CANCER IMMUNOLOGY IMMUNOTHERAPY. 72(2). p.475-491

Add to list

Journal Article
A1
open access

In vitro veritas : from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment

Dmitri Krysko (UGent) , Robin Demuynck (UGent) , Iuliia Efimova (UGent) , Faye Naessens (UGent) , Olga Krysko (UGent) and Elena Catanzaro (UGent)

(2022) CELLS. 11(22).

Add to list

Journal Article
A1
open access

Epithelial to mesenchymal transition influences fibroblast phenotype in colorectal cancer by altering miR‐200 levels in extracellular vesicles

Rahul Bhome, Muhammad Emaduddin, Victoria James, Louise M. House, Stephen M. Thirdborough, Massimiliano Mellone, Joeri Tulkens, John N. Primrose, Gareth J. Thomas, Olivier De Wever (UGent) , et al.

(2022) JOURNAL OF EXTRACELLULAR VESICLES. 11(5).

Add to list

A two-front nutritional environment fuels colorectal cancer : perspectives for dietary intervention

Elien Alderweireldt (UGent) , Charlotte Grootaert (UGent) , Olivier De Wever (UGent) and John Van Camp (UGent)

(2022) TRENDS IN ENDOCRINOLOGY AND METABOLISM. 33(2). p.105-119

Academic Bibliography

Glioma : bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy

Glioblastoma-associated mesenchymal stem/stromal cells and cancer-associated fibroblasts : partners in crime?

Targeting immunogenic cell death for glioma immunotherapy

Synthetic whole-slide image tile generation with gene expression profile-infused deep generative models

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

In vitro veritas : from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment

Epithelial to mesenchymal transition influences fibroblast phenotype in colorectal cancer by altering miR‐200 levels in extracellular vesicles

A two-front nutritional environment fuels colorectal cancer : perspectives for dietary intervention

Contents

Support

Contact